Sanofi to invest US$95 million in new Algeria project

ChristopherViehbacherSanofi has outlined plans to invest US$95mn to build a third plant in Algeria which is also expected to be its largest in the African continent

Sanofi said that it will invest US$95mn to build a manufacturing facility that at full capacity will be able to turn out 100mn units a year which will be about 80 per cent of the volume distributed by Sanofi in Algeria. It will produce both dry and liquid pharmaceutical forms, and include a distribution center.

Sanofi added that the plant will employ more than 130 workers. It expects it will take about three years to get it up and running.

The facility will be built on 6.6 hectares in a pharmaceutical and biotech cluster in the new town of Sidi Abdellah.

Sanofi CEO Christopher Viehbacher said it would be the largest in Africa. “We are aware that drugs alone are not enough to fight cardiovascular diseases, which is why Sanofi, in collaboration with the health authorities, will be providing solutions for public prevention, screening and education,” Viehbacher said.

Sanofi already has plants in Ain Benian and Oued S'mar.

Alain Charles Publishing, University House, 11-13 Lower Grosvenor Place, London, SW1W 0EX, UK
T: +44 20 7834 7676, F: +44 20 7973 0076, W:

twn Are you sure that you want to switch to desktop version?